The acquisition involves Torrent Pharma buying a 46.39 per cent stake from global investment firm KKR and an additional 2.8 ...

Torrent Pharma’s ₹25,689-crore acquisition of JB Chemicals boosts its chronic portfolio and expands its global reach. But ...

Torrent Pharmaceuticals acquires JB Chemicals to expand into new therapies and international markets, aiming for long-term ...

Torrent Pharma to acquire 2.41% more in JB Chemicals for ₹620 crore, following its ₹11,917 crore deal for a controlling stake ...

Notwithstanding the medium-term gains, the acquisition of JB Chemicals & Pharmaceuticals brings uncertainty over successful ...

Private equity giant KKR exits JB Chemicals with a ₹11,900 crore deal, reinforcing its track record in India's healthcare ...

In its latest move, the company has agreed to purchase an additional 2.41% stake for approximately ₹620 crore.

Brokerages see medium-term value in Torrent's ₹25,689 crore acquisition of JB Chemicals, despite near-term earnings dilution ...

Torrent Pharma announces acquisition of JB Chemicals & Pharmaceuticals, aiming to strengthen domestic and international ...

Cipla faces revenue and margin pressure due to the upcoming Revlimid patent expiry, leading to underperformance and analyst ...

Following the acquisition of JB Chemicals & Pharmaceuticals (JB Chem), Torrent Pharma is set to become India's fifth-largest ...

Torrent Pharma will emerge among the top 5 domestic pharma players by sales with the acquisition of J B Chemicals and ...